These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 20589648

  • 1. Continuously improving ifosfamide/mesna: a winning combination.
    Anderson P.
    Pediatr Blood Cancer; 2010 Oct; 55(4):599-600. PubMed ID: 20589648
    [No Abstract] [Full Text] [Related]

  • 2. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.
    Pratt CB.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456
    [Abstract] [Full Text] [Related]

  • 3. Ambulatory administration of 5-day infusion ifosfamide+mesna: a pilot study in sarcoma patients.
    Coriat R, Mir O, Camps S, Ropert S, Billemont B, Leconte M, Larousserie F, Anract P, Alexandre J, Goldwasser F.
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):491-5. PubMed ID: 19588140
    [Abstract] [Full Text] [Related]

  • 4. Full-dose ifosfamide can be safely administered to outpatients.
    Meazza C, Bisogno G, Casanova M, Zanetti I, Carli M, Ferrari A.
    Pediatr Blood Cancer; 2008 Feb; 50(2):375-8. PubMed ID: 16847930
    [Abstract] [Full Text] [Related]

  • 5. Ifosfamide and mesna: response and toxicity at standard- and high-dose schedules.
    Antman KH, Elias A, Ryan L.
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):68-73. PubMed ID: 2110386
    [Abstract] [Full Text] [Related]

  • 6. Mesna, doxorubicin, ifosfamide, and dacarbazine chemotherapy for ovarian mixed müllerian sarcoma: report of four cases.
    Patsner B, Greenberg S.
    Gynecol Oncol; 1995 Sep; 58(3):386-8. PubMed ID: 7672707
    [Abstract] [Full Text] [Related]

  • 7. Irreversible encephalopathy with ifosfamide/mesna.
    Salloum E, Flamant F, Ghosn M, Taleb N, Akatchereian C.
    J Clin Oncol; 1987 Aug; 5(8):1303-4. PubMed ID: 3114437
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Preliminary result of advanced soft tissue sarcoma treated by MAID regimen].
    Huang YH, Wen XP, Hu L.
    Ai Zheng; 2002 Aug; 21(8):907-9. PubMed ID: 12478905
    [Abstract] [Full Text] [Related]

  • 10. Ifosfamide in soft tissue sarcoma.
    Zaidi SH, Iqbal Z, Mallick JA.
    J Pak Med Assoc; 1990 Sep; 40(9):222-4. PubMed ID: 2123272
    [No Abstract] [Full Text] [Related]

  • 11. Ifosfamide in the treatment of soft tissue sarcomas.
    Connelly EF, Budd GT.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):16-21. PubMed ID: 8677442
    [Abstract] [Full Text] [Related]

  • 12. Ifosfamide combination regimens for soft-tissue sarcoma.
    Stuart-Harris R, Dalley D, Bell DR, Levi J, Simes RJ, Wiltshaw E.
    Cancer Chemother Pharmacol; 1993 Jun; 31 Suppl 2():S185-8. PubMed ID: 8453695
    [Abstract] [Full Text] [Related]

  • 13. Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma.
    Wiltshaw E, Westbury G, Harmer C, McKinna A, Fisher C.
    Cancer Chemother Pharmacol; 1986 Jun; 18 Suppl 2():S10-2. PubMed ID: 3102088
    [Abstract] [Full Text] [Related]

  • 14. Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma.
    Antman KH, Montella D, Rosenbaum C, Schwen M.
    Cancer Treat Rep; 1985 May; 69(5):499-504. PubMed ID: 3924401
    [Abstract] [Full Text] [Related]

  • 15. Severe renal failure following high-dose ifosfamide and mesna.
    Willemse PH, de Jong PE, Elema JD, Mulder NH.
    Cancer Chemother Pharmacol; 1989 May; 23(5):329-30. PubMed ID: 2495864
    [Abstract] [Full Text] [Related]

  • 16. Ifosfamide/mesna encephalopathy.
    McCallum AK.
    Lancet; 1987 Apr 25; 1(8539):987. PubMed ID: 2882385
    [No Abstract] [Full Text] [Related]

  • 17. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS, Felgenhauer J, Park J, Kreissman S, Thomson B, Douglas J, Rowley SD, Gooley T, Sanders JE, Pendergrass TW.
    Cancer; 2002 Sep 15; 95(6):1354-65. PubMed ID: 12216105
    [Abstract] [Full Text] [Related]

  • 18. Intravenous infusions of ifosfamide/mesna and perturbation of warfarin anticoagulant control.
    Hall G, Lind MJ, Huang M, Moore A, Gane A, Roberts JT, Cantwell BM.
    Postgrad Med J; 1990 Oct 15; 66(780):860-1. PubMed ID: 2129174
    [Abstract] [Full Text] [Related]

  • 19. Interstitial pneumonitis associated with ifosfamide therapy.
    Baker WJ, Fistel SJ, Jones RV, Weiss RB.
    Cancer; 1990 May 15; 65(10):2217-21. PubMed ID: 2112039
    [Abstract] [Full Text] [Related]

  • 20. Ifosfamide/mesna and hematuria.
    Pratt CB, Goren MP.
    Cancer Treat Rep; 1987 Nov 15; 71(11):1124-5. PubMed ID: 3119210
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.